Oxalic Acid

Oxalic Acid

SCHEMBL28068121

COC(N)=O.O=C(O)C(=O)O.O=C(O)C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.44
LDHB P07195 1/20 0.44
ALDH1A1 P00352 2/20 0.41
ACHE P22303 1/20 0.40
ALOX15 P16050 3/20 0.38
LMNA P02545 3/20 0.38
BLM P54132 2/20 0.38
PMP22 Q01453 2/20 0.38
TSHR P16473 5/20 0.35
HCAR2 Q8TDS4 2/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
NFKB1 P19838 2/20 0.33
OR51E2 Q9H255 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
THPO P40225 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Carbamate SCHEMBL27455257 0.89
Methyl Carbamate SCHEMBL27839791 0.89
Methyl Carbamate SCHEMBL788713 0.89 ALDH1A1 (0.50) ALDH1A1ACHEALOX15LMNABLM
Methyl Carbamate SCHEMBL4140 0.89
Benzene SCHEMBL27324158 0.86 TSHR (0.43) LDHALDHBALDH1A1ACHEALOX15
Methyl Carbamate SCHEMBL27967372 0.86 ACHE (0.50) LDHALDHBALDH1A1ACHEALOX15
Methyl Carbamate SCHEMBL50681 0.86
Methyl Carbamate SCHEMBL3465246 0.85
Methyl Carbamate SCHEMBL29248750 0.85
Methyl Carbamate SCHEMBL7127108 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105693700-B Bridged ring compound as hepatitis C inhibitor and preparation method thereof 广东东阳光药业有限公司 2019-01-04 CN disclosed
CN-105693700-A Bridged ring compound as hepatitis C inhibitor and preparation method thereof 广东东阳光药业有限公司 2016-06-22 CN disclosed